One CRISPR treatment cut “bad” cholesterol in half for a full year

cholesterol-plaque-in-bloodstream.webp

A single dose of an experimental CRISPR therapy cut LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders. The reductions were still present one year later, with the highest dose lowering LDL by 52.5% and triglycerides by 47.8%.

Continue reading...

[ H/T ScienceDaily ]
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read
  • Reading time 1 min read

Comments

There are no comments to display
Back
Top